Elevation Oncology Inc.

NASDAQ: ELEV · Real-Time Price · USD
0.38
0.06 (18.79%)
At close: Jun 09, 2025, 3:59 PM

Elevation Oncology Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.72 -0.4 -0.23 -4.36
PEG Ratio
0.02 0.01 -0.00 -0.05
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.54 0.33 0.45 0.99
P/FCF Ratio
-0.89 -0.33 -0.26 -4.63
P/OCF Ratio
-0.89 -0.33 -0.26 -4.63
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.52 0.55 0.60 n/a
Quick Ratio
21.21 21.22 5.93 17.00
Current Ratio
21.21 21.22 5.93 17.00
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-37.16 -10.9 -197.39 n/a
Return on Equity
-0.74 -0.83 -1.94 -0.23
Return on Assets
-0.47 -0.51 -1.01 -0.21
Return on Invested Capital
-0.49 -0.54 -1.21 -0.23
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a